Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hema Parmar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Endocrine-Related Cancer|September 17, 2004
Epithelial-stromal interactions in the mouse and human mammary gland in vivoHema Parmar, Gerald R Cunha
Gene|November 26, 2005
Identification of an epithelial-specific enhancer regulating ESX expressionRichard M Neve, Hema Parmar, Cliff Amend, et al.
Breast (Edinburgh, Scotland)|August 9, 2005
Hyperplasia, reduced E-cadherin expression, and developmental arrest in mammary glands oxidatively stressed by loss of mitochondrial superoxide dismutaseHema Parmar, Simon Melov, Enrique Samper, et al.
Cancer Research|January 20, 2004
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrestSreenivasan Paruthiyil, Hema Parmar, Vaishali Kerekatte, et al.
Endocrinology|November 26, 2002
A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblastsHema Parmar, Peter Young, Joanne T Emerman, et al.
Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.
Cancer Discovery|March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid TumorsDejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Endocrine-Related Cancer|September 17, 2004
Epithelial-stromal interactions in the mouse and human mammary gland in vivoHema Parmar, Gerald R Cunha
Gene|November 26, 2005
Identification of an epithelial-specific enhancer regulating ESX expressionRichard M Neve, Hema Parmar, Cliff Amend, et al.
Breast (Edinburgh, Scotland)|August 9, 2005
Hyperplasia, reduced E-cadherin expression, and developmental arrest in mammary glands oxidatively stressed by loss of mitochondrial superoxide dismutaseHema Parmar, Simon Melov, Enrique Samper, et al.
Cancer Research|January 20, 2004
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrestSreenivasan Paruthiyil, Hema Parmar, Vaishali Kerekatte, et al.
Endocrinology|November 26, 2002
A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblastsHema Parmar, Peter Young, Joanne T Emerman, et al.
Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.
Cancer Discovery|March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid TumorsDejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialChung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Pageof 1